Oppenheimer analyst Bryan Keane maintains SPX Technologies (NYSE:SPXC) with a Outperform and raises the price target from $77 to $82.
70 Stocks Moving In Monday’s Mid-Day Session
Gainers
Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares jumped 110% to $13.93 after the company announced initial data from the pivotal FIREFLY-1 trial of tovorafenib in relapsed pediatric low-grade glioma showed an overall response rate of 64%.
